Physta® was a realization from decades of research and development with a collaborative effort by worldwide scientists.

15 human clinical studies (GCP compliance) and 9 toxicology studies (GLP compliance) were conducted on Physta®.

Here are key people who have dedicated their lives in ensuring Eurycoma Longifolia continues to receive worldwide recognition as a safe and proven herbal product.

Dr. Annie George
Head, Science & Research, Biotropics Malaysia Berhad.

Professor Chokyun Rha
Professor of Biomaterials Sciences and Engineering at Massachusetts Institute of Technology (M.I.T., USA)

Dr. Anthony J. Sinskey
Professor of Microbiology at the Massachusetts Institute of Technology and holds positions as Co-Director of the Malaysia-MIT Biotechnology Partnership Program and as Faculty Director of the MIT Center for Biomedical Innovation (CBI). 

Dr. T. G. Sambandan

Researcher at Department of Materials Science and Engineering, Massachusetts Institute of Technology (M.I.T., USA).

Professor Emeritus
Dr Ismail Thambi

Clinical Consultant Andrologist and a Reproductive and Sexual Health Specialist, Damai Hospital, Kuala Lumpur.

Katsuiku Hirokawa

Professor of Emeritus in Pathology at Tokyo Medical and Dental University, Japan.

Professor Ralf Henkel

Senior Professor at Department of Medical Biosciences, University of the Western Cape, South Africa.

Dr. Sun Tao

A chief scientist, professor, and chief physician, with expertise in anti-aging and stem cell technologies, China.

Dr. Shawn Talbott

Fellow of both the American College of Sports Medicine and the American College of Nutrition, USA.

Dr. Jay Udani

Founder and CEO of Medicus Research LLC, USA